Marshall E. Eisenberg - 03 Nov 2021 Form 4 Insider Report for Sally Beauty Holdings, Inc. (SBH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Nov 2021, 16:35:41 UTC
Next SEC filing
04 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cade Newman, Attorney-in-Fact

Key filing fact

Marshall E. Eisenberg filed Form 4 for Sally Beauty Holdings, Inc. (SBH) on 05 Nov 2021.

Key facts

  • This page summarizes Marshall E. Eisenberg's Form 4 filing for Sally Beauty Holdings, Inc. (SBH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 Nov 2021, 16:35.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SBH transaction Derivative

Restricted stock units

Award

Transaction value
$0
Shares
+8,045
Change %
Price
$0.000000
Shares after
8,045
Date
03 Nov 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,045
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Grant of restricted stock units under the Sally Beauty Holdings, Inc. 2019 Omnibus Incentive Plan

Footnote F2

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F3

The restricted stock units vest on November 15, 2022. Vested shares will be delivered to the reporting person on the date such reporting person's service as a director of the issuer has terminated.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .